Selected research
Industry Growth & Trends
Global Neonatal Immune Cell Storage Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Neonatal Immune Cell Storage Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Neonatal Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Neonatal Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Neonatal Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Neonatal Immune Cell Storage Service market include Shanghai Cell Therapy Group, BGI Group, VCANBIO, CGT GLOBAL, Cordlife Group, ThermoGenesis, HealthBanks, BioLife Solutions and Sartorius, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Neonatal Immune Cell Storage Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Neonatal Immune Cell Storage Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neonatal Immune Cell Storage Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neonatal Immune Cell Storage Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Neonatal Immune Cell Storage Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Neonatal Immune Cell Storage Service Market by Company
Shanghai Cell Therapy Group
BGI Group
VCANBIO
CGT GLOBAL
Cordlife Group
ThermoGenesis
HealthBanks
BioLife Solutions
Sartorius
CGT GLOBAL
Cordlife Group
Aeterna Health
Cell Vault
Redermis
Innovita Research
Neonatal Immune Cell Storage Service Segment by Type
100ml Blood Collection Volume
150ml Blood Collection Volume
200ml Blood Collection Volume
Neonatal Immune Cell Storage Service Segment by Application
Personal
Commercial
Neonatal Immune Cell Storage Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neonatal Immune Cell Storage Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neonatal Immune Cell Storage Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neonatal Immune Cell Storage Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Neonatal Immune Cell Storage Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 100ml Blood Collection Volume
- 150ml Blood Collection Volume
- 200ml Blood Collection Volume
Applications
- Personal
- Commercial
Companies covered
- Shanghai Cell Therapy Group
- BGI Group
- VCANBIO
- CGT GLOBAL
- Cordlife Group
- ThermoGenesis
- HealthBanks
- BioLife Solutions
- Sartorius
- CGT GLOBAL
- Cordlife Group
- Aeterna Health
- Cell Vault
- Redermis
- Innovita Research
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Neonatal Immune Cell Storage Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Neonatal Immune Cell Storage Service Market Size by Region (2021-2032)
- 1.4.1 Global Neonatal Immune Cell Storage Service Market Size by Region (2021-2026)
- 1.4.2 Global Neonatal Immune Cell Storage Service Market Size by Region (2027-2032)
- 1.5 Key Regions Neonatal Immune Cell Storage Service Market Size (2021-2032)
- 1.5.1 North America Neonatal Immune Cell Storage Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Neonatal Immune Cell Storage Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Neonatal Immune Cell Storage Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Neonatal Immune Cell Storage Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Neonatal Immune Cell Storage Service Market Size Growth Rate (2021-2032)
2 Neonatal Immune Cell Storage Service Market by Type
- 2.1 Type Introduction
- 2.1.1 100ml Blood Collection Volume
- 2.1.2 150ml Blood Collection Volume
- 2.1.3 200ml Blood Collection Volume
- 2.2 Global Neonatal Immune Cell Storage Service Market Size by Type
- 2.2.1 Global Neonatal Immune Cell Storage Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Neonatal Immune Cell Storage Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Neonatal Immune Cell Storage Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Neonatal Immune Cell Storage Service Market Size by Regions
- 2.3.1 North America Neonatal Immune Cell Storage Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Neonatal Immune Cell Storage Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Neonatal Immune Cell Storage Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Neonatal Immune Cell Storage Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Neonatal Immune Cell Storage Service Market Size Breakdown by Type (2021-2026)
3 Neonatal Immune Cell Storage Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Personal
- 3.1.2 Commercial
- 3.2 Global Neonatal Immune Cell Storage Service Market Size by Application
- 3.2.1 Global Neonatal Immune Cell Storage Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Neonatal Immune Cell Storage Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Neonatal Immune Cell Storage Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Neonatal Immune Cell Storage Service Market Size by Regions
- 3.3.1 North America Neonatal Immune Cell Storage Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Neonatal Immune Cell Storage Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Neonatal Immune Cell Storage Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Neonatal Immune Cell Storage Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Neonatal Immune Cell Storage Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Neonatal Immune Cell Storage Service Industry Trends
- 4.2 Neonatal Immune Cell Storage Service Industry Drivers
- 4.3 Neonatal Immune Cell Storage Service Industry Opportunities and Challenges
- 4.4 Neonatal Immune Cell Storage Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Neonatal Immune Cell Storage Service Revenue (2021-2026)
- 5.2 Global Neonatal Immune Cell Storage Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Neonatal Immune Cell Storage Service Key Company Headquarters & Area Served
- 5.4 Global Neonatal Immune Cell Storage Service Company, Product Type & Application
- 5.5 Global Neonatal Immune Cell Storage Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Neonatal Immune Cell Storage Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Neonatal Immune Cell Storage Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Neonatal Immune Cell Storage Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Shanghai Cell Therapy Group
- 6.1.1 Shanghai Cell Therapy Group Company Information
- 6.1.2 Shanghai Cell Therapy Group Business Overview
- 6.1.3 Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Product Portfolio
- 6.1.5 Shanghai Cell Therapy Group Recent Developments
- 6.2 BGI Group
- 6.2.1 BGI Group Company Information
- 6.2.2 BGI Group Business Overview
- 6.2.3 BGI Group Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 BGI Group Neonatal Immune Cell Storage Service Product Portfolio
- 6.2.5 BGI Group Recent Developments
- 6.3 VCANBIO
- 6.3.1 VCANBIO Company Information
- 6.3.2 VCANBIO Business Overview
- 6.3.3 VCANBIO Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 VCANBIO Neonatal Immune Cell Storage Service Product Portfolio
- 6.3.5 VCANBIO Recent Developments
- 6.4 CGT GLOBAL
- 6.4.1 CGT GLOBAL Company Information
- 6.4.2 CGT GLOBAL Business Overview
- 6.4.3 CGT GLOBAL Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio
- 6.4.5 CGT GLOBAL Recent Developments
- 6.5 Cordlife Group
- 6.5.1 Cordlife Group Company Information
- 6.5.2 Cordlife Group Business Overview
- 6.5.3 Cordlife Group Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio
- 6.5.5 Cordlife Group Recent Developments
- 6.6 ThermoGenesis
- 6.6.1 ThermoGenesis Company Information
- 6.6.2 ThermoGenesis Business Overview
- 6.6.3 ThermoGenesis Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 ThermoGenesis Neonatal Immune Cell Storage Service Product Portfolio
- 6.6.5 ThermoGenesis Recent Developments
- 6.7 HealthBanks
- 6.7.1 HealthBanks Company Information
- 6.7.2 HealthBanks Business Overview
- 6.7.3 HealthBanks Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 HealthBanks Neonatal Immune Cell Storage Service Product Portfolio
- 6.7.5 HealthBanks Recent Developments
- 6.8 BioLife Solutions
- 6.8.1 BioLife Solutions Company Information
- 6.8.2 BioLife Solutions Business Overview
- 6.8.3 BioLife Solutions Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 BioLife Solutions Neonatal Immune Cell Storage Service Product Portfolio
- 6.8.5 BioLife Solutions Recent Developments
- 6.9 Sartorius
- 6.9.1 Sartorius Company Information
- 6.9.2 Sartorius Business Overview
- 6.9.3 Sartorius Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Sartorius Neonatal Immune Cell Storage Service Product Portfolio
- 6.9.5 Sartorius Recent Developments
- 6.10 CGT GLOBAL
- 6.10.1 CGT GLOBAL Company Information
- 6.10.2 CGT GLOBAL Business Overview
- 6.10.3 CGT GLOBAL Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio
- 6.10.5 CGT GLOBAL Recent Developments
- 6.11 Cordlife Group
- 6.11.1 Cordlife Group Company Information
- 6.11.2 Cordlife Group Business Overview
- 6.11.3 Cordlife Group Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio
- 6.11.5 Cordlife Group Recent Developments
- 6.12 Aeterna Health
- 6.12.1 Aeterna Health Company Information
- 6.12.2 Aeterna Health Business Overview
- 6.12.3 Aeterna Health Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Aeterna Health Neonatal Immune Cell Storage Service Product Portfolio
- 6.12.5 Aeterna Health Recent Developments
- 6.13 Cell Vault
- 6.13.1 Cell Vault Company Information
- 6.13.2 Cell Vault Business Overview
- 6.13.3 Cell Vault Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Cell Vault Neonatal Immune Cell Storage Service Product Portfolio
- 6.13.5 Cell Vault Recent Developments
- 6.14 Redermis
- 6.14.1 Redermis Company Information
- 6.14.2 Redermis Business Overview
- 6.14.3 Redermis Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Redermis Neonatal Immune Cell Storage Service Product Portfolio
- 6.14.5 Redermis Recent Developments
- 6.15 Innovita Research
- 6.15.1 Innovita Research Company Information
- 6.15.2 Innovita Research Business Overview
- 6.15.3 Innovita Research Neonatal Immune Cell Storage Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Innovita Research Neonatal Immune Cell Storage Service Product Portfolio
- 6.15.5 Innovita Research Recent Developments
7 North America
- 7.1 North America Neonatal Immune Cell Storage Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 7.3 North America Neonatal Immune Cell Storage Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Neonatal Immune Cell Storage Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 8.3 Europe Neonatal Immune Cell Storage Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Neonatal Immune Cell Storage Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Neonatal Immune Cell Storage Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Neonatal Immune Cell Storage Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 10.3 South America Neonatal Immune Cell Storage Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Neonatal Immune Cell Storage Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Neonatal Immune Cell Storage Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst